Portal
Order

MI Cancer Seek® is now available for clinical ordering. Learn more.

Home / Research / Publications / The Genomic, Transcriptomic, and Immunological Landscape of Sodium-glucose cotrasporter 2 in Lung Cancer and Association with Clinical Outcomes

Publications

Back

The Genomic, Transcriptomic, and Immunological Landscape of Sodium-glucose cotrasporter 2 in Lung Cancer and Association with Clinical Outcomes

– Caris Life Sciences

Poster

Conclusions

  • SLC5A2 expression was associated with a highly altered genomic landscape in AC
  • In specific subgroups, high expression of SLC5A2 was associated with OS and TOT with immunotherapy
Download Publication

Discover
More

  • Single-cell and spatial genomic landscape of non-small cell lung cancer brain metastases

    – Caris Life Sciences

    Manuscript

    Abstract Brain metastases frequently develop in patients with non-small cell lung cancer (NSCLC) and are a common cause of cancer-related deaths, yet our understanding of… […]

  • Real-world evidence provides clinical insights into tissue-agnostic therapeutic approvals

    – Caris Life Sciences

    Manuscript

    Abstract The US Food and Drug Administration approves tissue-agnostic therapies to target tumor biomarkers regardless of tumor type. In light of the growing number of… […]
Learn More

Ready to Get Started on the Journey?

Name(Required)